Panevėžio medicinos centras - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 109,291 | 129,886 | 122,802 | 158,136 | 178,210 | 196,515 | 190,326 | 181,911 |
| Profit before tax | 5,449 | 9,527 | -1,705 | -2,575 | 14,103 | 13,264 | 6,085 | -9,823 |
| Net profit | 5,334 | 8,847 | -1,705 | -2,575 | 13,051 | 12,512 | 5,682 | -9,823 |
| Equity | 3,220 | 12,067 | 10,362 | 7,787 | 20,838 | 33,349 | 39,032 | 29,209 |
| Liabilities | 89,509 | 84,309 | 76,582 | 64,823 | 53,700 | 19,304 | 23,510 | 19,786 |
| Non-current assets | 93,937 | 83,921 | 68,675 | 53,408 | 39,427 | 33,432 | 28,725 | 35,761 |
| Current assets | 24,866 | 32,742 | 32,768 | 27,914 | 38,035 | 19,915 | 34,511 | 28,436 |
| Total assets | 118,803 | 116,663 | 101,443 | 81,322 | 77,462 | 53,347 | 63,236 | 64,197 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 25,679 | 25,001 | 26,182 |
| Social insurance contributions | - | - | - | - | - | 22,517 | 23,595 | 24,508 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +12.1% | +18.8% | -5.5% | +28.8% | +12.7% | +10.3% | -3.1% | -4.4% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 4.5% | 7.6% | -1.7% | -3.2% | 16.8% | 23.5% | 9.0% | -15.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 165.7% | 73.3% | -16.5% | -33.1% | 62.6% | 37.5% | 14.6% | -33.6% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 4.9% | 6.8% | -1.4% | -1.6% | 7.3% | 6.4% | 3.0% | -5.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 5.0% | 7.3% | -1.4% | -1.6% | 7.9% | 6.7% | 3.2% | -5.4% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 27.8 | 7.0 | 7.4 | 8.3 | 2.6 | 0.6 | 0.6 | 0.7 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 5,123 | 5,860 | 5,712 | 7,973 | 8,729 | 10,209 | 12,021 | 13,230 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Panevėžio medicinos centras - Social security debts
The amount of overdue SODRA debt for the company Panevėžio medicinos centras as of the last working day is: 8 €
| From | To | Debt, € |
|---|---|---|
| 2026-09-16 | 2026-09-17 | 7.83 |
| 2026-08-19 | 2026-08-19 | 1979.27 |
| 2025-10-23 | 2025-10-30 | 1.73 |
| 2025-07-24 | 2025-08-17 | 6.43 |
| 2025-07-16 | 2025-07-20 | 1869.90 |
| 2025-06-17 | 2025-06-26 | 1852.78 |
| 2025-05-16 | 2025-05-18 | 1876.61 |
| 2023-12-18 | 2023-12-28 | 1899.16 |
Panevėžio medicinos centras - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Panevežio medicinos centras, UAB (code 148194320) is a Private Limited Liability Company engaged in medical specialists activities. In the latest financial year, 2025, the company generated revenue of €181.9K and reported a net loss of €9.8K, compared with net profit of €5.7K in 2024 and €12.5K in 2023. Revenue has declined gradually over the period, from €196.5K in 2023 to €190.3K in 2024 and €181.9K in 2025, while profitability weakened steadily before turning negative. The profit margin moved from 6.4% in 2023 to 3.0% in 2024 and -5.4% in 2025. Total assets increased slightly from €53.3K in 2023 to €64.2K in 2025. Equity stood at €29.2K at the end of 2025, with liabilities of €19.8K, giving an equity ratio of 45.5% and debt-to-equity of 0.68. Asset turnover was 2.83x in 2025. Revenue per employee was €14.0K, while profit per employee was -€756, indicating weaker operating performance in the latest year.